课题基金 / 基金详情

Cancer treatment by non-myeloablative hematopoietic stem cell transplant with Flt3L gene transfection.

Cancer treatment by non-myeloablative hematopoietic stem cell transplant with Flt3L gene transfection.
通过非清髓性造血干细胞移植和 Flt3L 基因转染进行癌症治疗。
批准号:
14571127
负责人:
ANDO Yuichi
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

ANDO Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
[Background] Dendritic cells are professional antigen presenting cells that can efficiently activate antigen specific T cells. Various strategies have been investigated to load antigen on dendritic cell for efficient CTL induction. Recent reports have shown that strong immune responses can be induced by dendritic cells transfected with antigen-coding or tumor-derived RNA using electroporation. However, the optimal condition of RNA-transfection with electroporation is still controversial. [Aim] We examined various conditions of RNA electroporation for dendritic cells to determine the optimal conditions for expression. [Materials and Methods] We used EGFP RNA transcribed in vitro from pTNT/EGFP and pGEM4Z/EGFP/A64, and lacZ RNA transcribed in vitro from pTNT/lacZ and pGEM4Z/lacZ/A64. In vitro transcribed RNA was transfected into day-7 bone marrow-derived dendritic cells of C57BL/6 mice with an. 5x10e6 cells in 200μl Opti-MEM (Invitrogen) were electroporated with RNA in 0.2-cm gapped cuve … More tte. Multiple conditions of voltage, pulse length, number of pulse and RNA amount were examined ranging between 200-lOOOV, 150-3000μs, 1-5pulses and 0-50μg, respectively. Effect of 0K-432 or LPS on EGFP expression in transfected dendritic cell was also examined.[Results] Flow cytometry and X-gal staining showed the expression of EGFP and 13 -galactosidase in dendritic cells electroporated with EGFP and lacZ RNA transcribed in vitro, respectively. Capped RNA better expressed EGFP than by RNA added β globin leader sequence or by uncapped RNA. The best efficiency with minor cell damage of electroporation was obtained with a condition at 300V, 500μs and one pulse. EGFP expression reached a plateau in DC transfected with 25μg-capped EGFP RNA. EGFP expression was detected in 12hr after electroporation, and was at its peak at 24hr after electroporation. LPS and OK-432 argued EGFP expression. [Conclusion] We demonstrated that RNA of interest could be efficiently transfected and expressed with electroporation. only with well-examined specific conditions. Less
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
安藤裕一, 別宮好文, 田原秀晃: "移植免疫からみた癌免疫療法の弱点"臨床外科. 57巻・10号. 1423-1428 (2002)
安藤雄一、别宫佳文、田原英明:“从移植免疫角度看癌症免疫疗法的弱点”《临床外科》第 57 卷,第 10 期。1423-1428(2002 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤 義一, 安藤裕一, 福澤正洋ら: "エレクトロポレーションを用いた樹状細胞RNAトランスフェクション条件検討"日大医学雑誌. (印刷中). (2004)
加藤嘉和、安藤雄一、福泽正宏等人:“使用电穿孔检查树突状细胞 RNA 转染的条件”,日本大学医学杂志(2004 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
安藤裕一, 別宮好文, 田原秀晃: "移植免疫からみた癌免疫療法の弱点"臨床外科. 57(10). 1423-1428 (2002)
Yuichi Ando、Yoshifumi Betsumiya、Hideaki Tahara:“从移植免疫的角度来看癌症免疫治疗的弱点”57(10)1423-1428(2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Kato, Y.Ando, M.Fukuzawa, H.Tahara.: "Optimal condition for RNA tranfection of dendritic cells using electroporation"Journal of Nihon University School of Medicine. (In press). (2004)
Y.Kato、Y.Ando、M.Fukuzawa、H.Tahara.:“使用电穿孔对树突状细胞进行 RNA 转染的最佳条件”日本大学医学院学报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Clinical and genetic factors of drug-induced QT interval prolongation in patients who receive cancer chemotherapy
    • 批准号:
      20590537
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.33万
    • 财政年份:
      2008
    • 负责人:
      ANDO Yuichi
    • 依托单位:
    Research of a model development for tooth loss prediction
    Tolerance induction by intrathymic injection of allopeptides.
    • 批准号:
      07807109
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1995
    • 负责人:
      ANDO Yuichi
    • 依托单位:
    国内基金
    海外基金
    Delta原钙黏蛋白(delta-protocadherin)在脊髓发育过程中的表达和功能调控研究
    • 批准号:
      31000475
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2010
    • 负责人:
      林俊堂
    • 依托单位: